Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 study of adding irinotecan to the FOLFOX regimen after radiation therapy for locally advanced rectal cancer to improv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer Ajcc V8
• Rectal Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING